Why the study?
Early diagnosis of hypokalemic periodic paralysis is crucial for prompt treatment and prevention of new attacks.
Identifies a novel CACNA1S mutation (p.R900M) associated with hypokalemic periodic paralysis and supports its pathogenicity through molecular modeling.
Answers are grounded in this paper and cite their sources.
Expands the known genetic spectrum of hypokalemic periodic paralysis to aid early diagnosis; leaves open.
Background Hypokalemic periodic paralysis (HypoKPP) is a rare neuromuscular genetic disorder causing recurrent episodes of flaccid paralysis. Most cases are associated with CACNA1S mutation, causing defect of calcium channel and subsequent impairment of muscle functions. Due to defined management approaches early diagnosis is crucial for promptly treatment and prevention new attacks. Materials and methods We report a case of HypoKPP associated with previously unreported mutation in CACNA1S gene (p.R900M). Molecular modeling of Ca V 1.1 was applied to evaluate its pathogenicity. Results As a patient referred between attacks neurological status, laboratory and neurophysiological examination were unremarkable. Molecular modeling predicted that the p.R900M mutation affects the process of calcium channels activation. Conclusion Novel CACNA1S mutation, associated with HypoKPP was identified. Monte-Carlo energy minimization of the Ca V 1.1 model supported the association of this mutation with this disease.
No takes yet. Share an insight, caveat, or question.
Нужный et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: